Status:
RECRUITING
Acceptance and Commitment Therapy for Patients Undergoing Coronary Artery Bypass Graft Surgery
Lead Sponsor:
University of Iowa
Conditions:
Coronary Artery Disease
Vascularization
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Heart disease is the leading cause of death globally, accounting for 16% of the world's total deaths. The number of cases is expected to increase as our population ages. Heart disease also results in ...
Eligibility Criteria
Inclusion
- admission to the Heart and Vascular Center at University of Iowa Hospitals and Clinics (UIHC) for urgent or elective CABG
- access to a personal phone or device with video or audio capabilities
- ability to provide informed consent
- English fluency.
Exclusion
- life-threatening comorbid (noncardiac) medical condition(s)
- active suicidal ideation or intent
- psychotropic medication use lasting less than four weeks
- inability to provide informed consent and comply with study procedures
- those undergoing repeat revascularization
Key Trial Info
Start Date :
February 12 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06207318
Start Date
February 12 2024
End Date
December 1 2025
Last Update
August 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States, 52242